Medium materiality6/10
Haemonetics price target raised to $125 from $105 at Raymond James
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Raymond James raises HAE target to $125; current price $102.96. Price change since signal -0.1.
Target: $125
Posted price: $102.96
Analyst firm: Raymond James
Analyst: Andrew Cooper
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.